Targeting GRB7/ERK/FOXM1 Signaling Pathway Impairs Aggressiveness of Ovarian Cancer Cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting GRB7/ERK/FOXM1 Signaling Pathway Impairs Aggressiveness of Ovarian Cancer Cells
Authors
Keywords
Ovarian cancer, Cancer cell migration, ERK signaling cascade, Cancer treatment, Cell proliferation, Signaling cascades, Mouse models, Pathogenesis
Journal
PLoS One
Volume 7, Issue 12, Pages e52578
Publisher
Public Library of Science (PLoS)
Online
2012-12-21
DOI
10.1371/journal.pone.0052578
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
- (2016) Linda S. Steelman et al. Aging-US
- Novel Nonphosphorylated Peptides with Conserved Sequences Selectively Bind to Grb7 SH2 Domain with Affinity Comparable to Its Phosphorylated Ligand
- (2012) Dan Zhang et al. PLoS One
- FOXM1: From cancer initiation to progression and treatment
- (2011) Chuay-Yeng Koo et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- FoxM1: A Master Regulator of Tumor Metastasis
- (2011) P. Raychaudhuri et al. CANCER RESEARCH
- Expression of FoxM1 Is Required for the Proliferation of Medulloblastoma Cells and Indicates Worse Survival of Patients
- (2011) M. Priller et al. CLINICAL CANCER RESEARCH
- MEK inhibitors: a patent review 2008 – 2010
- (2011) John I Trujillo EXPERT OPINION ON THERAPEUTIC PATENTS
- Structural Basis of Binding by Cyclic Nonphosphorylated Peptide Antagonists of Grb7 Implicated in Breast Cancer Progression
- (2011) Nigus D. Ambaye et al. JOURNAL OF MOLECULAR BIOLOGY
- Interaction of the non-phosphorylated peptide G7-18NATE with Grb7-SH2 domain requires phosphate for enhanced affinity and specificity
- (2011) Menachem J. Gunzburg et al. JOURNAL OF MOLECULAR RECOGNITION
- Aberrant Activation of ERK/FOXM1 Signaling Cascade Triggers the Cell Migration/Invasion in Ovarian Cancer Cells
- (2011) Gabriel T. M. Lok et al. PLoS One
- Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro
- (2010) Qi-fei Wu et al. ACTA PHARMACOLOGICA SINICA
- The Ras-ERK pathway: Understanding site-specific signaling provides hope of new anti-tumor therapies
- (2010) Fernando Calvo et al. BIOESSAYS
- Benzopyrazine derivatives: A novel class of growth factor receptor bound protein 7 antagonists
- (2010) Nigus D. Ambaye et al. BIOORGANIC & MEDICINAL CHEMISTRY
- GRB7 protein over-expression and clinical outcome in breast cancer
- (2010) Betsy Ramsey et al. BREAST CANCER RESEARCH AND TREATMENT
- How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?
- (2010) Yohannes Mebratu et al. CELL CYCLE
- Differential Functions of Growth Factor Receptor-Bound Protein 7 (GRB7) and Its Variant GRB7v in Ovarian Carcinogenesis
- (2010) Y. Wang et al. CLINICAL CANCER RESEARCH
- Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant Gliomas
- (2010) H.-W. Lo CURRENT CANCER DRUG TARGETS
- Emerging MEK inhibitors
- (2010) James A McCubrey et al. EXPERT OPINION ON EMERGING DRUGS
- The National Cancer Database report on advanced-stage epithelial ovarian cancer: Impact of hospital surgical case volume on overall survival and surgical treatment paradigm
- (2010) Robert E. Bristow et al. GYNECOLOGIC ONCOLOGY
- Microenvironment and Pathogenesis of Epithelial Ovarian Cancer
- (2010) Antonio F. Saad et al. Hormones & Cancer
- Ovarian Low-grade and High-grade Serous Carcinoma
- (2009) Russell Vang et al. ADVANCES IN ANATOMIC PATHOLOGY
- Targeting the RAF–MEK–ERK pathway in cancer therapy
- (2009) Clara Montagut et al. CANCER LETTERS
- Forkhead box M1 transcription factor: A novel target for cancer therapy
- (2009) Zhiwei Wang et al. CANCER TREATMENT REVIEWS
- Ovarian Cancer Pathogenesis: A Model in Evolution
- (2009) Alison M. Karst et al. Journal of Oncology
- Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells
- (2008) David W. Chan et al. CARCINOGENESIS
- Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis
- (2008) DW Chan et al. JOURNAL OF PATHOLOGY
- Focal Adhesion Kinase Controls Aggressive Phenotype of Androgen-Independent Prostate Cancer
- (2008) T. R. Johnson et al. MOLECULAR CANCER RESEARCH
- RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo
- (2008) A Bessard et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now